These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24795447)

  • 1. Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein.
    Paliwal D; Panda SK; Kapur N; Varma SPK; Durgapal H
    J Gen Virol; 2014 Aug; 95(Pt 8):1689-1700. PubMed ID: 24795447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by
    Saraswat S; Chaudhary M; Sehgal D
    Front Cell Infect Microbiol; 2019; 9():478. PubMed ID: 32039053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.
    Kanade GD; Pingale KD; Karpe YA
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protease Domain in HEV pORF1 Mediates the Replicase's Localization to Multivesicular Bodies and Its Exosomal Release.
    Glitscher M; Spannaus IM; Behr F; Murra RO; Woytinek K; Bender D; Hildt E
    Cell Mol Gastroenterol Hepatol; 2024; 17(4):589-605. PubMed ID: 38190941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.
    Karpe YA; Lole KS
    J Gen Virol; 2011 Sep; 92(Pt 9):2088-2092. PubMed ID: 21653754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein.
    Sehgal D; Thomas S; Chakraborty M; Jameel S
    Virol J; 2006 May; 3():38. PubMed ID: 16725054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.
    Zafrullah M; Ozdener MH; Kumar R; Panda SK; Jameel S
    J Virol; 1999 May; 73(5):4074-82. PubMed ID: 10196303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mann KS; Chisholm J; Sanfaçon H
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541838
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo modelling of HEV replication polyprotein: Five-domain breakdown and involvement of flexibility in functional regulation.
    Fieulaine S; Tubiana T; Bressanelli S
    Virology; 2023 Jan; 578():128-140. PubMed ID: 36527931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis.
    Kapur N; Thakral D; Durgapal H; Panda SK
    J Viral Hepat; 2012 Jun; 19(6):436-48. PubMed ID: 22571906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious.
    Panda SK; Ansari IH; Durgapal H; Agrawal S; Jameel S
    J Virol; 2000 Mar; 74(5):2430-7. PubMed ID: 10666275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin cleavage of the hepatitis E virus polyprotein at multiple conserved locations is required for genome replication.
    Pierce DM; Buchanan FJT; Macrae FL; Mills JT; Cox A; Abualsaoud KM; Ward JC; Ariëns RAS; Harris M; Stonehouse NJ; Herod MR
    PLoS Pathog; 2023 Jul; 19(7):e1011529. PubMed ID: 37478143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity.
    Parvez MK
    Virus Res; 2013 Dec; 178(2):553-6. PubMed ID: 23978667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells.
    Torresi J; Li F; Locarnini SA; Anderson DA
    J Gen Virol; 1999 May; 80 ( Pt 5)():1185-1188. PubMed ID: 10355765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the hepatitis E virus ORF1.
    Ropp SL; Tam AW; Beames B; Purdy M; Frey TK
    Arch Virol; 2000; 145(7):1321-37. PubMed ID: 10963340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1.
    Perttilä J; Spuul P; Ahola T
    J Gen Virol; 2013 Apr; 94(Pt 4):807-816. PubMed ID: 23255617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease.
    Parvez MK; Khan AA
    Virus Res; 2014 Jan; 179():220-4. PubMed ID: 24321124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR.
    Paliwal D; Joshi P; Panda SK
    PLoS One; 2017; 12(11):e0187334. PubMed ID: 29091957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in animal cells and characterization of the hepatitis E virus structural proteins.
    Jameel S; Zafrullah M; Ozdener MH; Panda SK
    J Virol; 1996 Jan; 70(1):207-16. PubMed ID: 8523527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.